meglumine has been researched along with Castleman Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, EY; Poole, PS; Santillan, CS | 1 |
Faust, JM; Hsieh, ML; Quint, LE; Turner, JE | 1 |
Debatin, JF; Dunnick, NR; Spritzer, CE | 1 |
3 other study(ies) available for meglumine and Castleman Disease
Article | Year |
---|---|
Case 172: Retroperitoneal Castleman disease (hyaline vascular type).
Topics: Castleman Disease; Contrast Media; Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Retroperitoneal Space; Tomography, X-Ray Computed; Young Adult | 2011 |
Enhancing mediastinal mass at MR: Castleman disease.
Topics: Adult; Biopsy; Castleman Disease; Contrast Media; Diagnosis, Differential; Drug Combinations; Gadolinium DTPA; Hemorrhage; Humans; Magnetic Resonance Imaging; Male; Mediastinal Diseases; Meglumine; Organometallic Compounds; Pentetic Acid; Tomography, X-Ray Computed | 1993 |
Castleman disease of the adrenal gland: MR imaging features.
Topics: Adrenal Gland Neoplasms; Adult; Castleman Disease; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Tomography, X-Ray Computed | 1991 |